Rationale: Vascular endothelial mitochondrial dysfunction contributes to the pathogenesis of several oxidant stress-associated disorders. Oxidant stress is a major contributor to the pathogenesis of bronchopulmonary dysplasia (BPD), a chronic lung disease of prematurity that often leads to sequelae in adult survivors.
Preterm birth has emerged as the most important cause of worldwide childhood mortality (1) . Bronchopulmonary dysplasia (BPD), characterized by impaired alveolar and lung vascular development, affects 25 to 50% of extremely low birth weight (birth weight [BW] , ,1 kg) premature infants (2) . Abnormalities in lung function seen in such infants persist into childhood and are second only to asthma in terms of childhood respiratory disease healthcare costs (3, 4) . Preterm birth exposes lungs that normally develop in a hypoxic intrauterine environment to a relatively hyperoxic environment, leading to increased reactive oxygen species (ROS) generation and to oxidant stress, which is an important pathogenetic factor for BPD.
Biomarkers of oxidant stress, such as serum malondialdehyde, and polymorphisms involving antioxidant response genes correlate strongly with abnormal lung function in preterm infants (5) (6) (7) . Mitochondria have been recognized as an important ROS source and as a key intracellular buffer that protects against such oxidant stress (8). Hyperoxia is known to inhibit pulmonary mitochondrial bioenergetic function and impair alveolar development in animal models of lung injury (9, 10) . Mitochondrial DNA (mtDNA) is exquisitely sensitive to oxidant injury, and hyperoxia-induced mtDNA damage has been shown to inhibit branching morphogenesis in rat lung explants, leading to abnormal alveolar maturation (11, 12) .
Abnormal lung vascular development is also a characteristic pathophysiologic feature of BPD (13) , and higher concentrations of endostatin (an angiogenesis inhibitor) have been found in tracheal aspirates of infants with BPD (14, 15) . Animal studies show that hyperoxia decreases endothelial mitochondrial antioxidant defenses and disrupts pulmonary endothelial tight junctions, leading to arrested pulmonary development (16) (17) (18) (19) (20) . Furthermore, hyperoxia-induced pulmonary capillary endothelial ROS generation increase is blocked by inhibition of the mitochondrial electron transport chain (ETC), suggesting that endothelial mitochondrial reactive oxygen species (mtROS) generated by hyperoxia contribute to lung injury (21) .
Taken together, this evidence suggests that vascular endothelial mitochondrial bioenergetic dysfunction, disordered ROS generation, and mtDNA damage may disrupt lung development in prematurely born infants. Human umbilical vein endothelial cells (HUVECs) have been used as model systems to study endothelial function in diseases such as hypertension (22) . Therefore, in this study, we hypothesized that impaired mitochondrial bioenergetics, increased ROS generation, and greater severity of mtDNA damage in HUVECs obtained from preterm infants at their birth would be associated with higher risk of BPD or death before 36 weeks postmenstrual age (PMA).
Methods Study Design and HUVEC Isolation
This prospective cohort study was approved by the University of Alabama at Birmingham Institutional Review Board. Informed consent was obtained from pregnant women at less than 32 weeks of gestation. Infants with congenital anomalies were excluded. BPD or death before 36 weeks PMA was used as the primary outcome. HUVECs were isolated from umbilical cords of enrolled infants and grown in culture. HUVEC growth rates were determined to ensure study feasibility. Passage-matched HUVECs from each infant were used for these experiments to ensure comparability between infants who died or developed BPD (BPD susceptible) and infants who survived without BPD (BPD resistant).
Bioenergetics
Second-passage HUVECs were used to measure intact cell bioenergetics using a Seahorse XFe/XF24 extracellular flux analyzer (Agilent Technologies, Santa Clara, CA). Briefly, basal oxygen consumption rate (OCR) and extracellular acidification rate were measured, followed by sequential measurements after addition of oligomycin to block ATP synthase (complex V of the ETC), carbonyl cyanide-ptrifluoromethoxyphenylhydrazone (FCCP) to stimulate mitochondrial oxygen consumption to maximal levels, and antimycin A/rotenone to inhibit substratederived electron transfer through ETC complexes III and I.
ROS Generation
HUVECs in their fourth passage were used. Fluorescence probes were purchased from Following exposure to hyperoxia, genomic DNA (gDNA) from fourth-passage HUVECs from 16 infants was extracted using a Genomic-tip and Genomic DNA Buffer set (QIAGEN, Valencia, CA) and quantified using Quant-iT PicoGreen fluorescence (Thermo Fisher Scientific). Long and short polymerase chain reactions for mtDNA and a short polymerase chain reaction for nuclear DNA were performed using similar quantities of gDNA from HUVECs of each infant to obtain relative mtDNA lesion frequency using term infant samples as controls. Relative mtDNA copy number per diploid nuclear genome was calculated to examine mitochondrial number differences between HUVECs from BPD-resistant infants and BPDsusceptible infants.
Statistical Analysis
Fisher's exact test was used for betweengroup comparisons of categorical variables, and Student's t test, the MannWhitney U test, and analysis of variance were used for continuous variables. Logistic regression models and a classification tree to predict BPD or death were developed using R software packages (R Foundation for Statistical Computing, Vienna, Austria) and a set of 11 independent variables. More details regarding all the experimental methods described above are provided in the online supplement. Of the 69 infants in the study, 35 (51%) developed BPD or died, 24 of whom survived with BPD and 11 of whom died (median age, 3 d) before their BPD status could be assessed at 36 weeks PMA. As would be expected for a disease of prematurity, gestational age (GA) and BW were lower for BPD-susceptible infants than for BPD-resistant survivors; infants who died had the lowest GA and BW compared with the infants who survived with BPD and infants who survived without BPD (mean 6 SD GA, 23 6 1 vs. 26 6 2 vs. 27 6 2 wk, respectively; mean 6 SD BW, 443 6 187 vs. 770 6 276 vs. 1,057 6 412 g, respectively; P , 0.05 for both comparisons). Clinical differences noted between BPD-resistant and BPD-susceptible infants are shown in Table 1 . The online supplement contains additional comparisons of study variables between infants who survived without BPD, those who survived with BPD, and those who died before they could be assessed for BPD (see Table E1 in the online supplement).
At a Glance Commentary
Decreased HUVEC Oxygen Consumption in BPD-Susceptible Infants HUVEC basal mitochondrial OCR was lower for BPD-susceptible infants than for BPD-resistant infants (n = 35 vs. n = 34; mean 6 SEM, 66 6 6 vs. 121 6 11 pmol/min/3 3 10 4 cells; P , 0.001). Similarly, maximal mitochondrial HUVEC oxygen consumption, measured after the addition of FCCP, was lower in BPDsusceptible infants than in BPD-resistant infants (mean 6 SEM, 107 6 8 vs. 235 6 22 pmol/min/3 3 10 4 cells; P , 0.001), as was reserve mitochondrial capacity for oxygen consumption (mean 6 SEM, 40 6 7 vs. 114 6 14 pmol/min/3 3 10 4 cells; P , 0.001), indicating decreased HUVEC mitochondrial bioenergetic function ( Figure 1 ). HUVEC response to inhibited mitochondrial respiration (increased anaerobic glycolysis) was measured as extracellular acidification rate, but no differences were noted between HUVECs from BPD-susceptible infants and BPDresistant infants, either at baseline or after mitochondrial effector injections (mean 6 SEM basal, 17 6 2 vs. 18 
Increased HUVEC Proton Leak in BPD-Susceptible Infants
Baseline intact cellular oxygen uptake ( Figure E2B ) is consumed by mitochondrial ATP synthase to generate ATP (ATP-linked OCR) in cycling of protons across a "leaky" inner mitochondrial membrane (proton leak) and for nonmitochondrial oxidative processes (e.g., nicotinamide adenine dinucleotide phosphate oxidases). ATP-linked OCR was lower for HUVECs from BPD-susceptible infants than for BPD-resistant infants (n = 35 vs. n = 34, respectively; mean 6 SEM, 44 6 4 vs. 89 6 9 pmol/min/3 3 10 4 cells; P , 0.001). HUVECs obtained from BPD-susceptible infants and BPD-resistant infants did not differ in the percentages of baseline cellular oxygen uptake used for ATP synthesis (mean, 47 vs. 51%; P . 0.05) or for nonmitochondrial consumption (mean, 27 vs. 30%; P . 0.05). However, HUVECs from BPD-susceptible infants had a higher proportion of their baseline oxygen uptake consumed by proton leak than those obtained from BPD-resistant infants (mean, 26 vs. 19%; P , 0.05), suggesting increased uncoupling of mitochondrial ATP generation from oxygen consumption ( Figure 2 ).
Increased HUVEC mtROS Generation in BPD-Susceptible Infants
In a normoxic environment, HUVEC mitochondria from BPD-susceptible infants generated more O : À 2 than those from BPDresistant infants (n = 35 vs. n = 34; mean 6 SEM, 130,250 6 19,062 vs. 73,526 6 12,031 MitoSOX fluorescence units; P , 0.05). (Figure 3 ).
Fluorescence quantification in images of DHR123-labeled HUVECs from eight infants in each group indicated increased global ROS generation in HUVECs derived from BPD-susceptible infants compared with those from BPD-resistant infants ( Figure 4) . Finally, colocalization of corresponding DHR123-and MitoTracker Red-labeled HUVEC images showed increased rhodamine fluorescence in mitochondria of HUVECs from BPDsusceptible infants, providing more evidence to suggest that these infants have increased endothelial mtROS generation than BPD-resistant infants (see representative images in Figure E3 ).
Increased HUVEC mtDNA Damage in BPD-Susceptible Infants
Because the findings of decreased mitochondrial bioenergetics and increased ROS generation suggested increased oxidant load in HUVECs from BPD-susceptible infants, we next measured mtDNA lesion frequency. HUVEC mtDNA damage ( Figure 5 ) was higher in BPD-susceptible infants than in BPD-resistant infants (n = 8 for each group; mean 6 SEM, 2.5 6 0.7 vs. 0.4 6 0.2 DNA lesions per kb; P , 0.05). We also observed that mtDNA copy number normalized to gDNA was similar between the two groups (mean 6 SEM, 2.8 6 0.2 vs. 2.5 6 0.3 relative mtDNA copy number; P . 0.05). This indicates similar mitochondrial content in HUVECs obtained from BPD-susceptible infants compared with BPD-resistant infants, but more precise estimates using other mitochondrial markers such as citrate synthase activity in a larger sample size are required to accurately determine mitochondrial content in these cells. Several clinical variables were examined for their effects on HUVEC bioenergetic and redox function. HUVECs from infants exposed to maternal hypertension or preeclampsia had similar basal and maximal mitochondrial OCR compared with those from infants without such exposure (n = 31 and n = 38; mean 6 SEM, 139 6 11 vs. 115 6 12 and 195 6 20 vs. 150 6 19 pmol/min/3 3 10 4 cells, respectively; P . 0.05 for both comparisons). However, HUVECs from infants exposed to chorioamnionitis (infection and inflammation of the fetal membranes and placental layers) had lower basal and maximal mitochondrial OCR than those from infants without such exposure (n = 29 and n = 40; mean 6 SEM, 68 6 9 vs. 112 6 9 and 113 6 15 vs. 212 6 19 pmol/min/3 3 10 4 cells, respectively; P , 0.001 for both comparisons), and they had higher H 2 O 2 content in their supernatants (mean 6 SEM, 2,015 6 306 vs. 900 6 139 resorufin fluorescence units, respectively; P , 0.001). HUVEC oxygen consumption also varied on the basis of race. African American (AA) infants had lower basal and maximal oxygen consumption than white infants (n = 32 per group; mean 6 SEM, 75 6 14 vs. 115 6 10 and 113 6 16 vs. 212 6 19 pmol/min/3 3 10 4 cells, respectively; P , 0.05 for both comparisons) and higher H 2 O 2 content in their supernatants (mean 6 SEM, 1,892 6 299 vs. 945 6 145 resorufin fluorescence units, respectively; P , 0.001), as shown in Figure 6 .
HUVEC Maximal OCR Identified as a Significant Death/BPD Predictor
In addition to individual pairwise comparisons, we developed logistic regression models for the outcome of death or BPD using 11 predictor variables in a training cohort of 35 infants randomly selected from among the 69 infants in our study. Analysis of the relative importance of all 11 variables averaged across all possible logistic regression models to predict death or BPD revealed maximal OCR to be a highly significant predictor (Table 2) . Maximal HUVEC OCR and hyperoxiainduced HUVEC H 2 O 2 release (Table 3) were also shown to be the most significant predictors for death or BPD in the final model. The McFadden pseudo R 2 score, a measure of logistic regression goodness of fit, was found to be 0.78 for this model. When applied to the testing cohort of 34 infants, its accuracy in predicting death or BPD status was 89% (95% confidence interval, 84-94%; sensitivity, 90%; specificity, 94%). Robustness was estimated using the leave-one-out cross-validation method and showed that the model had a 13% error rate in predicting death or BPD status for the entire cohort. Receiver operating characteristic curve analysis revealed an area under the curve of 0.89 ( Figure 7A ). In addition, we also derived a classification tree model for BPD or death using a classification and regression tree algorithm using all 11 variables as predictors. Maximal HUVEC oxygen consumption less than 200 pmol/min/3 3 10 4 cells, GA less than 28 weeks, and BW less than 850 g were found to be highly predictive of death before discharge or of BPD for prematurely born infants ( Figure 7B ).
HUVEC Growth Rates and mtDNA Copy Number
To determine if HUVEC growth rate differences due to GA or BPD susceptibility affected our experimental results, we tested for possible associations between these factors. We observed poor correlation for HUVEC proliferation and apoptosis rates with GA from 23 to 32 weeks (n = 35; r = 0.20; P . 0.05; and n = 26; r = 20.17; P . 0.05, respectively) ( Figure E1 ). In addition, growth rates of HUVECs between BPD-susceptible infants and BPD-resistant infants (quantified as gDNA content obtained from HUVEC cultures that were grown using similar cellseeding densities for 1 wk in similar conditions) also did not show significant differences (n = 8 in each group; mean 6 SEM, 1.5 6 0.1 vs. 1.3 6 0.1 ng/µL, respectively; P . 0.05). HUVEC bioenergetics, ROS generation, and mtDNA damage comparisons between discrete outcomes (infants who survived without BPD vs. those who survived with BPD and those who died before they could be assessed for BPD) are available in the online supplement (Table E1 ).
Discussion
Our objective in the present study was to determine whether impaired vascular endothelial mitochondrial function is a predictor of risk for early death or BPD. Compared with HUVECs from BPDresistant infants, HUVECs from infants who died or developed chronic lung disease had lower basal and maximal mitochondrial OCR and a lower reserve capacity for oxidative phosphorylation. Compared with HUVECs from BPD-resistant survivors, HUVECs from infants who died or developed chronic lung disease also produced more ROS, including mitochondrial-derived O : À 2 ; released more H 2 O 2 into their environment; and had increased mtDNA damage with hyperoxia exposure. Regression analysis identified maximal HUVEC OCR as the most significant variable associated with BPD or death. In addition to decreased absolute oxygen consumption (indicating poor mitochondrial health), these HUVECs also had a higher proportion of their baseline OCR lost to proton leak, implying that their mitochondria had increased futile oxygen consumption that was uncoupled from ATP generation (23) .
Endothelial ATP depletion can induce premature cellular aging and limit endothelial cell survival during hyperoxia (24) . Pulmonary angiogenesis is a key component of alveolar development. 
ORIGINAL ARTICLE
Stimulation of vascularization with proangiogenic factors such as fibroblast growth factor 2 and angiopoietin 1 augments pulmonary alveolar growth, and endothelial-epithelial interactions are necessary for normal morphogenesis of branching distal airways, especially in the saccular stage of lung development, during which most premature infants who will develop BPD are born (25) (26) (27) . Endothelial bioenergetic dysfunction could thus lead to dysfunctional interaction between a depleted vascular endothelium and the developing alveolar epithelium as well as to functionally inadequate lung architecture. Hyperoxic endothelial bioenergetic failure can also lead to pulmonary edema and inflammation, as observed in the newborn rat lung (28) . Therefore, increased uncoupling and decreased HUVEC mitochondrial function seen in BPD-susceptible infants indicate that similar bioenergetic dysfunction in the pulmonary vascular endothelium could accelerate pulmonary endothelial senescence, decrease alveolarization, and increase inflammation in the developing lung.
Another important mitochondrial function is generation of mtROS at low levels for signaling and cell function regulation. H 2 O 2 , a membrane diffusible ROS, is involved in several elements of vascular endothelial function, such as modulation of hypoxia-inducible factor-1a activity and endothelial proliferation (29) (30) (31) . However, mitochondrial uncoupling, which was observed in BPDsusceptible HUVECs, often generates supraphysiologic amounts of mtROS that decrease endothelial cell viability and diffuse into surrounding cells to cause vascular smooth muscle hypertrophy or initiate apoptotic cascades to inhibit alveolar epithelial wound repair (32) (33) (34) . mtROS also amplify inflammatory responses in pulmonary venular capillaries exposed to hyperoxia (35) . Our finding of Estimates for all 11 variables chosen for logistic regression model building were averaged across all fitted models using the "glmulti" package in R. On the basis of their relative importance averaged across all models, maximal HUVEC OCR and HUVEC supernatant H 2 O 2 content were found to be the most significant predictors of risk for death or bronchopulmonary dysplasia in premature infants in our study.
increased mtDNA damage in HUVECs from BPD-susceptible infants that produced increased amounts of mtROS also suggests that mitochondrial injury is exacerbated by hyperoxia-induced mtROS in vascular endothelial cells in these infants.
Thus, both increased signaling through mtROS indicative of increased oxidant stress and the more deleterious effects of increased ROS generation may be active in the pulmonary vasculature of BPDsusceptible infants.
Race and exposure to perinatal inflammation were identified as factors affecting HUVEC bioenergetic function. Chorioamnionitis exposure, as noted in our study, is not consistently associated with increased BPD, but it is known to amplify ORIGINAL ARTICLE inflammatory responses to other stimuli that cause lung injury (36, 37) . Our findings of increased mtROS generation in HUVECs from AA infants are supported by our own findings of enhanced oxidative stress in HUVECs from healthy term AA infants and by findings in other studies (38, 39) . Therefore, the endothelial bioenergetic and redox dysfunction seen in these infant subgroups indicates potential mechanisms through which BPD risk could be amplified in specific infants.
Methodologic strengths of this study include quantitative measurements of ROS generation and mtDNA damage in humanderived cells from a unique patient population for an exploratory study of this nature. We used intact cells to measure bioenergetic function in endothelial cells to eliminate artifacts associated with mitochondrial isolation (40) . We also ascertained that potential differences in HUVEC growth rates in culture due to developmental differences (GA effects) or due to varying susceptibility to BPD in these infants that might affect our experimental results did not exist. Finally, we used robust and cross-validated statistical models to verify our primary hypothesis that HUVEC bioenergetics is an important predictor of BPD in premature infants.
Our study is also subject to certain limitations. Extrapolation of HUVEC biology to other vascular endothelial beds that often have heterogeneous responses to oxidant damage may be of limited value (41) . However, HUVEC monolayer models for the study of microvascular pathophysiology have several merits, and we have used them successfully in previous studies (42) . Additionally, fluorescence-based methods for measurement of ROS such as O : À 2 and H 2 O 2 are prone to issues such as mitotoxicity from these dyes and the relative nonspecificity of their oxidation by multiple oxidants (43) . To mitigate such concerns, we used modified experimental methods such as the use of O : À 2 -specific excitation ranges for the MitoSOX Red experiments (44) . Finally, endothelial cells are primarily glycolytic, and the relative contribution of oxidative phosphorylation and glycolysis in early-passage HUVECs that we used for this study remains unknown (45) . We observed similar HUVEC glycolytic rates in infants with different BPD susceptibility, but we acknowledge that more precise characterization using chemical inhibitors of glycolysis needs to be obtained.
In summary, vascular endothelial mitochondrial function at birth is a potential biomarker for BPD susceptibility in preterm infants. Evaluation of HUVEC mitochondrial biology could be valuable for studying pathology related to prematurity in general and for studying endothelial and lung biology. Recent advances in highthroughput technology have permitted bioenergetic analyses in a variety of biological structures, and researchers have proposed novel biomarkers, such as a personalized "bioenergetic health index," to quantify an individual's bioenergetic health (46) . Such individualized bioenergetic measures derived from readily accessible cells such as HUVECs could help modify therapeutic strategies to decrease risk for adverse pulmonary outcomes in susceptible infants. n Author disclosures are available with the text of this article at www.atsjournals.org.
